Historical Valuation
Anterix Inc (ATEX) is now in the Fair zone, suggesting that its current forward PS ratio of 71.31 is considered Fairly compared with the five-year average of -25.76. The fair price of Anterix Inc (ATEX) is between 2.08 to 85.48 according to relative valuation methord.
Relative Value
Fair Zone
2.08-85.48
Current Price：22.38
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Anterix Inc (ATEX) has a current Price-to-Book (P/B) ratio of 1.73. Compared to its 3-year average P/B ratio of 3.54 , the current P/B ratio is approximately -51.08% higher. Relative to its 5-year average P/B ratio of 3.94, the current P/B ratio is about -56.07% higher. Anterix Inc (ATEX) has a Forward Free Cash Flow (FCF) yield of approximately -6.26%. Compared to its 3-year average FCF yield of -0.48%, the current FCF yield is approximately 1195.71% lower. Relative to its 5-year average FCF yield of -0.16% , the current FCF yield is about 3788.11% lower.
P/B
Median3y
3.54
Median5y
3.94
FCF Yield
Median3y
-0.48
Median5y
-0.16
Competitors Valuation Multiple
AI Analysis for ATEX
The average P/S ratio for ATEX competitors is 16.49, providing a benchmark for relative valuation. Anterix Inc Corp (ATEX.O) exhibits a P/S ratio of 71.31, which is 332.49% above the industry average. Given its robust revenue growth of 0.06%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for ATEX
1Y
3Y
5Y
Market capitalization of ATEX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ATEX in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ATEX currently overvalued or undervalued?
Anterix Inc (ATEX) is now in the Fair zone, suggesting that its current forward PS ratio of 71.31 is considered Fairly compared with the five-year average of -25.76. The fair price of Anterix Inc (ATEX) is between 2.08 to 85.48 according to relative valuation methord.
What is Anterix Inc (ATEX) fair value?
ATEX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Anterix Inc (ATEX) is between 2.08 to 85.48 according to relative valuation methord.
How does ATEX's valuation metrics compare to the industry average?
The average P/S ratio for ATEX's competitors is 16.49, providing a benchmark for relative valuation. Anterix Inc Corp (ATEX) exhibits a P/S ratio of 71.31, which is 332.49% above the industry average. Given its robust revenue growth of 0.06%, this premium appears unsustainable.
What is the current P/B ratio for Anterix Inc (ATEX) as of Jan 10 2026?
As of Jan 10 2026, Anterix Inc (ATEX) has a P/B ratio of 1.73. This indicates that the market values ATEX at 1.73 times its book value.
What is the current FCF Yield for Anterix Inc (ATEX) as of Jan 10 2026?
As of Jan 10 2026, Anterix Inc (ATEX) has a FCF Yield of -6.26%. This means that for every dollar of Anterix Inc’s market capitalization, the company generates -6.26 cents in free cash flow.
What is the current Forward P/E ratio for Anterix Inc (ATEX) as of Jan 10 2026?
As of Jan 10 2026, Anterix Inc (ATEX) has a Forward P/E ratio of -70.57. This means the market is willing to pay $-70.57 for every dollar of Anterix Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Anterix Inc (ATEX) as of Jan 10 2026?
As of Jan 10 2026, Anterix Inc (ATEX) has a Forward P/S ratio of 71.31. This means the market is valuing ATEX at $71.31 for every dollar of expected revenue over the next 12 months.